264 related articles for article (PubMed ID: 23255514)
21. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
22. Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF.
Mak W; Kondapalli LA; Celia G; Gordon J; DiMattina M; Payson M
Hum Reprod; 2016 Apr; 31(4):789-94. PubMed ID: 26908846
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of mode of conception and infertility treatment on fetal growth and prematurity.
Valenzuela-Alcaraz B; Crispi F; Manau D; Cruz-Lemini M; Borras A; Balasch J; Gratacós E
J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3879-84. PubMed ID: 26856245
[TBL] [Abstract][Full Text] [Related]
24. Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors.
Del Pup L; Peccatori FA; Levi-Setti PE; Codacci-Pisanelli G; Patrizio P
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):8042-8059. PubMed ID: 30536354
[TBL] [Abstract][Full Text] [Related]
25. Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women.
Klip H; van Leeuwen FE; Schats R; Burger CW;
Hum Reprod; 2003 Sep; 18(9):1951-8. PubMed ID: 12923156
[TBL] [Abstract][Full Text] [Related]
26. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
27. The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up.
Kessous R; Davidson E; Meirovitz M; Sergienko R; Sheiner E
J Cancer Res Clin Oncol; 2016 Jan; 142(1):287-93. PubMed ID: 26337160
[TBL] [Abstract][Full Text] [Related]
28. In vitro fertilization and breast cancer risk: a review.
Salhab M; Al Sarakbi W; Mokbel K
Int J Fertil Womens Med; 2005; 50(6):259-66. PubMed ID: 16526416
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients.
Venn A; Jones P; Quinn M; Healy D
Gynecol Oncol; 2001 Jul; 82(1):64-8. PubMed ID: 11426963
[TBL] [Abstract][Full Text] [Related]
31. Ovarian stimulation: is there a long-term risk for ovarian, breast and endometrial cancer?
Lerner-Geva L; Rabinovici J; Lunenfeld B
Womens Health (Lond); 2010 Nov; 6(6):831-9. PubMed ID: 21118041
[TBL] [Abstract][Full Text] [Related]
32. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis.
Vercellini P; Consonni D; Dridi D; Bracco B; Frattaruolo MP; Somigliana E
Hum Reprod; 2014 May; 29(5):964-77. PubMed ID: 24622619
[TBL] [Abstract][Full Text] [Related]
33. Is ovarian hyperstimulation associated with higher blood pressure in 4-year-old IVF offspring? Part I: multivariable regression analysis.
Seggers J; Haadsma ML; La Bastide-Van Gemert S; Heineman MJ; Middelburg KJ; Roseboom TJ; Schendelaar P; Van den Heuvel ER; Hadders-Algra M
Hum Reprod; 2014 Mar; 29(3):502-9. PubMed ID: 24365797
[TBL] [Abstract][Full Text] [Related]
34. Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study.
Courbiere B; Decanter C; Bringer-Deutsch S; Rives N; Mirallié S; Pech JC; De Ziegler D; Carré-Pigeon F; May-Panloup P; Sifer C; Amice V; Schweitzer T; Porcu-Buisson G; Poirot C;
Hum Reprod; 2013 Sep; 28(9):2381-8. PubMed ID: 23832792
[TBL] [Abstract][Full Text] [Related]
35. Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation?
Kapiteijn K; de Bruijn CS; de Boer E; de Craen AJ; Burger CW; van Leeuwen FE; Helmerhorst FM
Hum Reprod; 2006 Dec; 21(12):3228-34. PubMed ID: 17023490
[TBL] [Abstract][Full Text] [Related]
36. The use of aromatase inhibitors in in vitro fertilization.
Garcia-Velasco JA
Fertil Steril; 2012 Dec; 98(6):1356-8. PubMed ID: 23062732
[TBL] [Abstract][Full Text] [Related]
37. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis.
Li J; Liu R; Tang S; Feng F; Liu C; Wang L; Zhao W; Zhang T; Yao Y; Wang X; Sun C
Arch Gynecol Obstet; 2019 Jan; 299(1):35-46. PubMed ID: 30460611
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes.
Sunkara SK; La Marca A; Seed PT; Khalaf Y
Hum Reprod; 2015 Jun; 30(6):1473-80. PubMed ID: 25883033
[TBL] [Abstract][Full Text] [Related]
39. Live birth and perinatal outcomes following stimulated and unstimulated IVF: analysis of over two decades of a nationwide data.
Sunkara SK; LaMarca A; Polyzos NP; Seed PT; Khalaf Y
Hum Reprod; 2016 Oct; 31(10):2261-7. PubMed ID: 27591229
[TBL] [Abstract][Full Text] [Related]
40. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.
Zhang M; Niu W; Wang Y; Xu J; Bao X; Wang L; Du L; Sun Y
J Assist Reprod Genet; 2016 Aug; 33(8):981-91. PubMed ID: 27094195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
